ReviewRSC advances2025
Recent exploration of inorganic sonosensitizers for sonodynamic therapy of tumors.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress on the induction of immunogenic cell death in tumor immunotherapy using a sonodynamic therapy nanoparticle delivery system.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the rapid development of nanomedicine and nanobiotechnology, various therapeutic methods have been applied with good efficacy and biological safety. As a non-invasive treatment method, sonodynamic therapy (SDT) can effectively treat deep tumors with less damage to the surrounding tissue and high adaptability. The ultrasound sensitizer is an indispensable and important part of the SDT process, and its structure and properties directly determine the therapeutic effect of SDT. Compared with conventional organic sonosensitizers, inorganic sonosensitizers including noble metal-based, transition metal-based, silicon-based and carbon-based sonosensitizers have high stability, controllable morphology and long circulation time in the human body, which has greatly expanded their research applications in SDT. In this review, the possible mechanisms of SDT,
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.